Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 84
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07003074 | A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer | ||
| NCT06230588 | A Clinical Trial of TQH3906 Capsules in Healthy Volunteers | ||
| NCT07179679 | A Clinical Study Assessing the Subcutaneous Formulation of TQB2934 for Injection in Subjects With Malignant Plasma Cell Tumors | ||
| NCT06962267 | A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type) | ||
| NCT05032937 | the Accuracy and Safety of Coronary Artery Contrast-enhanced Magnetic Resonance Imaging With Polysaccharide Superparamagnetic Iron Oxide Nanoparticle | ||
| NCT07008976 | Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer | ||
| NCT06146751 | A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging for the Detection of Intracardiac Thrombus | ||
| NCT06798207 | A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced | ||
| NCT06496490 | A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality | ||
| NCT06569524 | Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) | ||
| NCT05213767 | Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB2916 Injection in Patients With Advanced Malignant Tumors | ||
| NCT05033587 | Study of AK105 With Anlotinib and Radiotherapy Adjuvant Therapy in MGMT Unmethylated Newly Diagnosed Glioblastoma. | ||
| NCT05409326 | A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects | ||
| NCT06219096 | Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection | ||
| NCT07653685 | A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer | ||
| NCT06172322 | A Phase Ib/Ⅱ Study of NTQ1062 in Combination With Fulvestrant in Patients With Advanced HR Positive /HER-2 Negative Breast Cancer | ||
| NCT06106841 | TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT06433531 | A Clinical Study of TQH2929 Injection in Treatment With Generalized Pustular Psoriasis (GPP) | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT07113925 | A Clinical Trial Evaluating TQB2101 in Subjects With Advanced Hematologic Malignancies | ||
| NCT06076486 | A Clinical Trial to Evaluate Efficacy and Safety of Elagolix Tablets in Women With Moderate or Severe Endometriosis-associated Pain | ||
| NCT01833923 | A Phase I Study of Anlotinib on Tolerance and Pharmacokinetics | ||
| NCT06764303 | A Study of NTQ5082 Capsules in the Treatment of Paroxysmal Nocturnal Hemoglobinuria Patients | ||
| NCT07047365 | TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer | ||
| NCT06948539 | To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors | ||
| NCT06789289 | A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease | ||
| NCT06977763 | Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection | ||
| NCT06700395 | A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma | ||
| NCT06767800 | A Clinical Trial Evaluating TQB2102 for Injection in Combination With Behmosubaisumab/Payamprolizumab With or Without Chemotherapy in Unresectable Locally Advanced, Recurrent, or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Gastroesophageal Adenocarcinoma | ||
| NCT07043725 | A Clinical Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT07406035 | A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis | ||
| NCT07177872 | A Long-term Efficacy and Safety of NTQ5082 Capsules | ||
| NCT07462130 | An Efficacy and Safety Study of NTB003 in Participants With Thyroid Eye Disease (TED) | ||
| NCT06156280 | A Clinical Study of TQH2929 in Healthy Adult Subjects | ||
| NCT05193604 | A Clinical Trial to Evaluate Tolerability and Security of TQB2858 Injection in Subjects With Advanced Pancreatic Carcinoma | ||
| NCT06452706 | The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer | ||
| NCT07182552 | Phase I Clinical Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics of NTB003 in Healthy Participants | ||
| NCT07156643 | A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma. | ||
| NCT05192512 | Clinical Trial of the TQB2928 Injection in Patients With Advanced Cancers | ||
| NCT07043751 | A Clinical Trial Evaluating Injection of TQB6411 in Subjects With Advanced Malignant Tumors | ||
| NCT06438783 | TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors | ||
| NCT07724366 | A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis | ||
| NCT05735496 | Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers | ||
| NCT07745439 | A Drug-Drug Interaction Study Between NTQ5082 Capsules and Midazolam Oral Solutio | ||
| NCT06672263 | A Clinical Trial to Evaluate the Safety and Tolerability of TQB3911 Tablets in Patients With BCR::ABL Fusion Gene Positive Leukemia | ||
| NCT05262101 | Clinical Trial of TQB2858 Injection in the Treatment of Advanced High-grade Sarcoma | ||
| NCT05198505 | Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT06542614 | Treatment of Moderate to Severe Plaque Psoriasis | ||
| NCT06188624 | Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers | ||
| NCT07052097 | Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis |
